Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
JAMA
|
February 13, 2019
Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections
Renaud Prevel, Driss Berdaï, Alexandre Boyer
Joint Bone Spine
|
November 13, 2012
Licensing of antirheumatic drugs: are the EMA and FDA on the same page?
Bernard Bannwarth, Driss Berdaï, Marie Kostine
Therapie
|
May 10, 2021
Time to define common European criteria for therapeutic added value
Denis Boucaud-Maitre, Francesco Salvo, Driss Berdaï
Therapie
|
January 2, 2022
Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives
Sibylle de Germay, Driss Berdaï, Pernelle Noize
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 1, 2021
Added Therapeutic Value of Medicinal Products for French and German Health Technology Assessment Organizations: A Systematic Comparison
Denis Boucaud-Maitre, Driss Berdaï, Francesco Salvo
Therapie
|
July 10, 2016
[Not Available]
Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Therapie
|
September 22, 2010
Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European level
Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Therapie
|
October 19, 2019
Pharmacovigilance - The next chapter
Nicholas Moore, Driss Berdaï, Patrick Blin, et al.
La Revue Du Praticien
|
October 15, 2020
[Therapeutic education, compliance and self-medication]
Pietro Rosellini, Driss Berdaï, Mathieu Molimard, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE
|
April 13, 2022
The Multidimensional Nature of Research Ethics: Letters Issued by a French Research Ethics Committee Included Similar Proportions of Ethical and Scientific Queries
Thibaud Haaser, Vincent Bouteloup, Driss Berdaï, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
JAMA
|
February 13, 2019
Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections
Renaud Prevel, Driss Berdaï, Alexandre Boyer
Joint Bone Spine
|
November 13, 2012
Licensing of antirheumatic drugs: are the EMA and FDA on the same page?
Bernard Bannwarth, Driss Berdaï, Marie Kostine
Therapie
|
May 10, 2021
Time to define common European criteria for therapeutic added value
Denis Boucaud-Maitre, Francesco Salvo, Driss Berdaï
Therapie
|
January 2, 2022
Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives
Sibylle de Germay, Driss Berdaï, Pernelle Noize
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 1, 2021
Added Therapeutic Value of Medicinal Products for French and German Health Technology Assessment Organizations: A Systematic Comparison
Denis Boucaud-Maitre, Driss Berdaï, Francesco Salvo
Therapie
|
July 10, 2016
[Not Available]
Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Therapie
|
September 22, 2010
Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European level
Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Therapie
|
October 19, 2019
Pharmacovigilance - The next chapter
Nicholas Moore, Driss Berdaï, Patrick Blin, et al.
La Revue Du Praticien
|
October 15, 2020
[Therapeutic education, compliance and self-medication]
Pietro Rosellini, Driss Berdaï, Mathieu Molimard, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE
|
April 13, 2022
The Multidimensional Nature of Research Ethics: Letters Issued by a French Research Ethics Committee Included Similar Proportions of Ethical and Scientific Queries
Thibaud Haaser, Vincent Bouteloup, Driss Berdaï, et al.
Page
of 4